Barclays Maintains Underweight on FMC, Lowers Price Target to $4

Barclays analyst Benjamin Theurer has maintained an Underweight rating on FMC (NYSE:FMC) and reduced the price target from $9 to $4. This adjustment reflects a more cautious outlook on the company's performance.